Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-24-000541
Filing Date
2024-01-29
Accepted
2024-01-29 16:36:38
Documents
78
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 10-K organicellregen_10k.htm   iXBRL 10-K 1890223
2 EXHIBIT 23.1(A) organicellregen_ex23-1a.htm EX-23.1(A) 3621
3 EXHIBIT 23.1(B) organicellregen_ex23-1b.htm EX-23.1(B) 3908
4 EXHIBIT 31.1 organicellregen_ex31-1.htm EX-31.1 12541
5 EXHIBIT 31.2 organicellregen_ex31-2.htm EX-31.2 11830
6 EXHIBIT 32.1 organicellregen_ex32-1.htm EX-32.1 4333
7 EXHIBIT 32.2 organicellregen_ex32-2.htm EX-32.2 4306
8 GRAPHIC img_001.jpg GRAPHIC 83904
  Complete submission text file 0001829126-24-000541.txt   8142820

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ocel-20231031.xsd EX-101.SCH 72767
10 XBRL CALCULATION FILE ocel-20231031_cal.xml EX-101.CAL 74547
11 XBRL DEFINITION FILE ocel-20231031_def.xml EX-101.DEF 246371
12 XBRL LABEL FILE ocel-20231031_lab.xml EX-101.LAB 419431
13 XBRL PRESENTATION FILE ocel-20231031_pre.xml EX-101.PRE 367082
79 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_10k_htm.xml XML 1058545
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-55008 | Film No.: 24574183
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)